Boxer Capital’s Million Corvus Bet Signals Confidence
Boxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
This article breaks down the key drivers behind global stock indices, including economic data, central bank policy, and market sentiment.
20,453 articlesBoxer Capital quietly boosted its stake in Corvus Pharmaceuticals, a move that signals institutional faith in the bio...
The AI boom isn’t over. If you felt you missed the first wave, these three resilient stocks deliver real AI leverage,...
Investing in Micron today means evaluating AI-driven memory demand, pricing power, and the memory market cycle. This ...
As DocuSign navigates a changing digital transaction landscape, the docusign (DOCU) 2027 earnings thesis hinges on re...
SpaceX IPO buzz is rising, but the hype can mislead older investors. A new market briefing outlines the risks and pra...
A new AI narrative is taking shape. Nvidia Jensen Huang Just outlined a path where autonomous AI agents could transfo...
Traders weigh covered calls on mega-cap tech as volatility stays elevated. This article explains how much yield could...
In July, investors are weighing recession risks against reliable income. This guide highlights three dividend staples...
NVDY investors are prioritizing regular income over Nvidia-driven gains, a trade that has weighed on NAV and long-ter...
Microsoft is riding a fast-growing AI wave, but its stock hasn’t followed the surge. Here’s how analysts and models v...
Two pharmaceutical giants are in court over GLP-1 advertising. This tangle could redefine how GLP-1s are marketed and...
Hims Hers continues to blend telehealth with consumer products. This guide breaks down the key metrics from the earni...